The Great Disruptors, Inc

Trethera Corp, based in Sherman Oaks, CA, is a biotechnology company focused on developing innovative treatment approaches for solid tumors and autoimmune diseases. Leveraging insights into metabolic pathways, their lead product candidate, TRE-515, targets nucleotide metabolism to inhibit cancer cell growth while potentially addressing immune system dysregulation in autoimmune disorders. By strategically inhibiting the enzyme dCK, Trethera aims to disrupt nucleotide biosynthesis in cancer cells, offering a promising therapeutic strategy for specific tumor types and potential combination therapies. Their research efforts have garnered attention for their potential impact on diseases like multiple sclerosis and Crohn's disease, highlighting a commitment to advancing precision medicine in oncology and autoimmune conditions.Generated from the website

Dnatwo, Inc is a technology company based in Sherman Oaks, CA, specializing in developing innovative software solutions for various industries. With a focus on cutting-edge research and development, the company is dedicated to creating bespoke software products tailored to meet the unique needs of its clients. Generated from their business information

MabSwitch Inc. is a biotechnology company based in Van Nuys, CA, focused on developing and commercializing innovative products utilizing affinity switches for antibodies. Their pioneering approach aims to enhance patient outcomes through next-generation immunotherapeutics, diagnostics, and immunoaffinity reagents. Through their proprietary Universal Allosteric Linker and Switch Module for Antibodies (UNASMA) technology, MabSwitch seeks to address significant challenges in the application of antibodies, such as regulating binding affinity in therapeutic and diagnostic settings. With the increasing demand for antibody-based products, the company is positioned at the forefront of biotechnology advancements. Generated from the website